Associations between methylation at SLC6A4 with cardiometabolic markers implies potential functional relevance of methylation at these sites in contributing to obesity and other cardiovascular or metabolic diseases. The gene discussed is SLC6A4; the disease is obesity due to melanocortin 4 receptor deficiency.